© 2019 Vasoptic Medical Inc.

1215 E. Fort Ave Suite 304
Baltimore, MD 21230

Non-invasive measurement of retinal blood flow using the XyCAM RI™ retinal imaging system: early clinical results

September 3, 2016

ARVO Annual Meeting Abstract  |   September 2016




Quantification of retinal blood flow shows promise as an early biomarker for diverse ocular pathologies such as diabetic retinopathy and glaucoma. We have developed a non-invasive retinal imaging device—the XyCAM RITM—that captures high-resolution fundus images and uses laser speckle contrast imaging (LSCI) to estimate retinal blood flow.




The right eye of 4 healthy individuals (58-59 years old, 2 male) received tropicamide for pupil dilation and was imaged using the investigational XyCAM RI in a clinical environment. Subjects’ heads were stabilized on a standard clinical chin rest and the XyCAM RI mounted on a slit lamp base for fine motion adjustment (Fig. 1A). Four imaging sessions were conducted on each subject, where each session comprised of an ophthalmologist focusing on a desired region of interest (ROI) in the subject’s retina, followed by rapid, automatic acquisition of 5 red-free fundus photographs (with green illumination) and 120 speckle images (using red laser illumination). For reference, color fundus photographs were also obtained using a Topcon TRC 50DX fundus camera.
At least 4 vessel ROIs were identified in each fundus photograph and retinal blood flow velocities (RBFV) were estimated within those ROIs using LSCI-based methods. For each subject, statistical analyses were completed using data from the session with the lowest variation in RBFV estimates.


Full Abstract

Share on Facebook
Share on Twitter
Please reload

Recent News

Vasoptic Medical impresses at ARVO 2017

May 30, 2017

Vasoptic Medical's $1.5 million cash infusion pushes it toward FDA approval

April 24, 2017

Title: Ophthalmic examination and disease management with multiple illumination modalities

Patent No. US9492083

Vasoptic receives another patent issuance from The United States Patent and Trademark Office (USPTO)

November 15, 2016

Please reload